Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Fibroblast Growth Factor 21 (FGF21), Free Fatty Acid (FFA), High Sensitivity C-reactive Protein (hsCRP) and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Among Indonesian Obese Non-Diabetic Males

The Indonesian Biomedical Journal · Vol. 1 No. 3 (2009) · hlm. 76–76

DOI
10.18585/inabj.v1i3.103
ISSN
2085-3297, 2355-9179
Terbit
2009-12-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Fibroblast growth factor-21 (FGF21) is known as an important endocrine and paracrine regulator of metabolic homeostasis. Recent studies have shown that FGF21 attenuates lipolysis in human adipocytes, which is suggested as a FGF21's mechanism as anti-hyperlipidemia, anti-hyperglycemia and anti-obesity. The aim of this study was to measure the correlation between FGF21, FFA, hsCRP and HOMA-IR among Indonesian obese non diabetic males.METHOD: The study was observational with cross sectional design. The analysis was done in 137 subjects aged 30-60 years with non diabetic abdominal obesity. We measured the biochemical markers FGF21, FFA, hsCRP, fasting insulin and fasting glucose. We also measured weight, height, waist circumrefence (WC), creatinine, serum glutamin oxaloacetic transaminase (SGOT), and serum glutamic pyruvic transaminase (SGPT), systolic blood pressure (SBP) and diastolic blood pressure (DBP). Correlation between markers was measured using Pearson and Spearman's analysis. RESULT: There were significant positive correlations between FGF21-HOMA-IR (r=0.314, p=0.000); FGF21-WC (r=0.173, p=0.043); FFA=hsCRP (r=0.270, p=0.001); and WC-HOMA-IR (r=0.279, p=0.001). There was significant negative correlation between FGF21-FFA (r=-0.038, p=0.657) and FGF21-hsCRP (r=-0.061, p=0.482). CONCLUSION: In this study we found that although there was no significant correlation, FGF21 might act as an anti-lipolytic and anti-inflammation agent among Indonesian obese non-diabetic males. Our findings agree with results of previous studies that the positive correlation between FGF21-WC and FGF21-HOMA-IR moght occur as a compensatory mechanism or resistance to FGF21 in obesity.KEYWORDS: Obesity, FGF21, FFA, hsCRP, HOMA-IR

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 149 tautan kepenulisan bersama · 44 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • Diponegoro University
  • Padjadjaran University
  • PT Prodia StemCell Indonesia (Indonesia)
  • Udayana University
  • University of Indonesia
  • Universitas Airlangga
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anna MeilianaPadjadjaran University90
Nurrani Mustika DewiPadjadjaran University45
Cynthia Retna SartikaPT Prodia StemCell Indonesia (Indonesia)6
Ilhamjaya PatellongiHasanuddin University6
Syakib BakriHasanuddin University6
Teguh RanakusumaUniversity of Indonesia5
Anwar SantosoUdayana University4
Trilis YuliantiHasanuddin University4
Yenny SurjawanHasanuddin University4
Agussalim BukhariHasanuddin University3
Andi Yasmin SyaukiHasanuddin University3
Nurbaya SyamHasanuddin University3
Irawan YusufHasanuddin University3
Rima HaifaPT Prodia StemCell Indonesia (Indonesia)3
Marsetio DonosepoetroUniversitas Airlangga3
Citra KesumasariHasanuddin University2
AminuddinHasanuddin University2
Mardiana MadjidHasanuddin University2
Nur ASHARIHasanuddin University2
Nur Ainun RaniHasanuddin University2
Andi FaradilahHasanuddin University2
A Arsyi A P SADIKINHasanuddin University2
Rizky Suganda PrawiradilagaBandung Islamic University2
Nurpudji Astuti TaslimHasanuddin University2
Burhanuddin BaharHasanuddin University2
Zakaria ZakariaIPB University2
Veni HadjuHasanuddin University2
Ari YuniastutiState University of Semarang2
Sri Achadi NugraheniDiponegoro University2
Pingkan FristiwiDiponegoro University2
Fatimah Asri Fadhilah AuliaDiponegoro University2
Shafa Alya KamilaDiponegoro University2
Irfan IdrisHasanuddin University2
Hamsu KadriyanUniversity of Mataram2
Irma Ruslina DefiPadjadjaran University2
Bachtiar MurtalaHasanuddin University2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Fibroblast Growth Factor 21 (FGF21), Free Fatty Acid (FFA), High Sensitivity C-reactive Protein (hsCRP) and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Among Indonesian Obese Non-Diabetic Males</dc:title><dc:creator>Yani Lina</dc:creator><dc:creator>Gatot Susilo Lawrence</dc:creator><dc:creator>Andi Wijaya</dc:creator><dc:creator>Suryani As’ád</dc:creator><dc:subject>FGF21</dc:subject><dc:subject>free fatty acids</dc:subject><dc:subject>high-sensitivity C-reactive protein</dc:subject><dc:subject>insulin resistance</dc:subject><dc:subject>abdominal obesity</dc:subject><dc:subject>non-diabetic obesity</dc:subject><dc:subject>waist circumference</dc:subject><dc:subject>anti-inflammatory activity</dc:subject><dc:subject>metabolic homeostasis</dc:subject><dc:subject>Indonesian men</dc:subject><dc:subject>fasting insulin</dc:subject><dc:subject>fasting blood glucose</dc:subject><dc:subject>lipid profile</dc:subject><dc:subject>blood pressure</dc:subject><dc:subject>liver enzymes</dc:subject><dc:subject>adipocytes</dc:subject><dc:subject>compensatory mechanisms</dc:subject><dc:description xml:lang="en">BACKGROUND: Fibroblast growth factor-21 (FGF21) is known as an important endocrine and paracrine regulator of metabolic homeostasis. Recent studies have shown that FGF21 attenuates lipolysis in human adipocytes, which is suggested as a FGF21's mechanism as anti-hyperlipidemia, anti-hyperglycemia and anti-obesity. The aim of this study was to measure the correlation between FGF21, FFA, hsCRP and HOMA-IR among Indonesian obese non diabetic males.METHOD: The study was observational with cross sectional design. The analysis was done in 137 subjects aged 30-60 years with non diabetic abdominal obesity. We measured the biochemical markers FGF21, FFA, hsCRP, fasting insulin and fasting glucose. We also measured weight, height, waist circumrefence (WC), creatinine, serum glutamin oxaloacetic transaminase (SGOT), and serum glutamic pyruvic transaminase (SGPT), systolic blood pressure (SBP) and diastolic blood pressure (DBP). Correlation between markers was measured using Pearson and Spearman's analysis. RESULT: There were significant positive correlations between FGF21-HOMA-IR (r=0.314, p=0.000); FGF21-WC (r=0.173, p=0.043); FFA=hsCRP (r=0.270, p=0.001); and WC-HOMA-IR (r=0.279, p=0.001). There was significant negative correlation between FGF21-FFA (r=-0.038, p=0.657) and FGF21-hsCRP (r=-0.061, p=0.482). CONCLUSION: In this study we found that although there was no significant correlation, FGF21 might act as an anti-lipolytic and anti-inflammation agent among Indonesian obese non-diabetic males. Our findings agree with results of previous studies that the positive correlation between FGF21-WC and FGF21-HOMA-IR moght occur as a compensatory mechanism or resistance to FGF21 in obesity.KEYWORDS: Obesity, FGF21, FFA, hsCRP, HOMA-IR</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2009-12-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v1i3.103</dc:identifier><dc:identifier>10.18585/inabj.v1i3.103</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 1 No 3 (2009); 76-76</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/103/129</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>